Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31

Libyan Journal of Medicine

Volumn 6, Issue 1, 2011, Pages 1-6

  El Gehani, Khaled ^a   Al Kikhia, Lamia ^a   Mansuri, Naziha ^b   Syrjänen, Kari ^c   Al Fituri, Omran ^a   Elzagheid, Adam ^a  

^a UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

^b African Oncology Institute   (Libyan Arab Jamahiriya)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Angiogenesis; Bladder carcinoma; CD31; Factor VIII; Microvessel density

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLADDER CARCINOMA; BLOOD VESSEL PARAMETERS; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVESSEL DENSITY; PREDICTIVE VALUE; PROGNOSIS; TUMOR VASCULARIZATION;

EID: 80053602302     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v6i0.6016     Document Type: Article

References (21)

1. Folkman J. Angiogenesis and angiogenesis inhibition: an overview. EXS. 1997; 79: 1-8.
2. Inoue K, Slaton JW, Karashima T. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res. 2000; 6: 4866-73.
3. Chabannes E, Bernardini S, Wallerand H, Bittard H. Angiogenesis in bladder: prognosis indicator and therapeutic target. Prog Urol. 2001; 11: 417-27.
4. Jemal A, Siegel R, Ward E. Cancer statistics. CA Cancer J Clin. 2007; 57: 43-66.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr
6. Chaudhary R, Bromley M, Clarke NW, Betts CD, Barnard RJ, Ryder WD, et al. Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res. 1999; 19: 3479-84.
7. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996; 86: 353-64.
8. Delisser HM. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol. 1997; 151: 671-77.
9. Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. Oncol Rep. 2005; 14: 251-55.
10. Korkolopoulou P, Konstantinidou AE, Kavantzas N, Patsouris E, Pavlopoulos PM, Christodoulou P, et al. Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch. 2001; 438: 603-11.
11. Sagol O, Yorukoglu K, Sis B, Tuna B, Ozer E, Guray M, et al. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder? Urology. 2001; 57: 895-99.
12. Chikazawa M, Inoue K, Fukata S, Karashima T, Shuin T. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Pathobiology. 2008; 75: 335-45.
13. Suzuki K, Morita T, Tokue A. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol. 2005; 12: 152-58.
14. Beecken WD, Engl T, Jonas D, Blaheta RA. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy. Int J Mol Med. 2009; 23: 261-66.
15. Herrmann E, Bogemann M, Bierer S, Eltze E, Toma MI, Kopke T, et al. The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis. Oncol Rep. 2007; 18: 133-38.
16. Stavropoulos NE, Bouropoulos C, Ioachim IE, Michael M, Hastazeris K, Tsimaris I, et al. Prognostic significance of angiogenesis in superficial bladder cancer. Int Urol Nephrol. 2004; 36: 163-67.
17. Bochner B, Esrig D, Groshen S, Dickinsin M, Weidner N, Nichols PW. Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. Clin Cancer Res. 1997; 3: 1615-22.
18. Santos L, Koch M, Costa C, Pereira S, Amaro T, Cardoso F, et al. Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumors. Ann Oncol. 2003; 14: 1419-24.
19. Emad E, El-Baz M, Gomha M, Abol-Enein H, Shaaban AA. Prognostic value of angiogenesis in schistosoma-associated squamous cell carcinoma of the urinary bladder. Urology. 2002; 60: 69-73.
20. Ozer E, Mungan MU, Tuna B, Kazimoglu H, Yorukoglu K, Kirkali Z. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer. Urology. 1999; 54: 50-55.
21. Canoglu A, Gogus C, Beduk Y, Orhan D, Tulunay O, Baltaci S. Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis. Int Urol Nephrol. 2004; 36: 401-5.